Alvaro Pereira-Rico, MD's SharePosts

Medical Oncologist's Response to Luteinizing Hormone-Releasing Hormone (LH-RH) Agonist Study

by Alvaro Pereira-Rico, MD on Breast Cancer
Friday, May 18 2007

Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study on luteinizing hormone-releasing hormone (LH-RH) agonists, drugs that decrease the level of estrogen and other sex hormones in women. LH-RH agonists for breast cancer treatment are used in Europe and... Read more Chevron

Be the first to comment |

Notify me when there are new comments

Related Breast Cancer Topics

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Alvaro Pereira-Rico, MD's SharePosts

Medical Oncologist's Response to Luteinizing Hormone-Releasing Hormone (LH-RH) Agonist Study

Ask a Question